EZZ Life Science Holdings Ltd. recently announced an update regarding a new share issuance. The Australian genomic life science company revealed that they have issued 1,708,200 new shares to a sophisticated investor at $0.50 each. This issuance was done under section 708A(5)(e) of the Corporations Act, allowing the transaction to proceed without the need for disclosure to investors.
EZZ Life Science Holdings Ltd. is known for its focus on addressing significant health challenges and has a strong e-commerce presence. The company has confirmed that they have complied with all necessary legal provisions in regards to the share issuance. It was also noted that no excluded information was required to be disclosed in this particular notice.
For those interested in further insights into AU:EZZ stock, TipRanks’ Stock Analysis page is a valuable resource to check out. With EZZ Life Science Holdings Ltd.’s recent update, investors can stay informed on the company’s latest developments and activities in the genomic life science sector.
Investors looking for more information on EZZ Life Science Holdings Ltd.’s recent share issuance can find it here: [insert link].
